Dechra Pharmaceuticals announced it has acquired the rights to an equine lameness treatment, HY-50 (sodium hyaluronate), from Bexinc for C$8 million ($8 million). Dechra has gained worldwide rights, excluding Canada, for the intra-articular (IA) or intravenous treatment (IV) of lameness in horses caused by joint dysfunction.

Source: Brakke Consulting

Novartis Animal Health issued a “Dear Doctor” letter to veterinarians cautioning that foreign tablets may be found in certain bottles of Clomicalm (clomipramine hydrochloride) tablets. No instances of foreign tablets in Clomicalm bottles have been reported to Novartis; the letter was issued as a precautionary measure after its consumer health division recalled several human products packaged at a facility in Lincoln, Nebraska over similar concerns.

Novartis Animal Health reported full year sales of $1.30 billion in 2011, an increase of 7% over 2011 sales (4.5% in constant currency). Growth during 2011 reflects strong growth performance in Germany, Japan, Australia and the emerging markets.

Source: Brakke Consulting

FlavorX has announced the launch of its Digital Flavorist software, giving veterinarians and pharmacists complete veterinary compounding and flavoring instructions with just a few quick keystrokes. Following the recipes generated by the Digital Flavorist, veterinarians and pharmacists can easily turn solid-form medications into flavored liquids.

Source: Brakke Consulting

Bio Health Solutions announced the launch of RenAvast, a new supplement for cats with chronic renal failure. RenAvast contains Avastamine, a combination of naturally occurring amino acids and peptides.

Source – Brakke Consulting

Bayer Animal Health GmbH and AgraQuest, Inc. announced that they have agreed to expand their collaboration and will allow Bayer to become the exclusive distributor of AgraQuest’s Bacillus subtilis QST 713 in selected countries for poultry applications. The product that will be distributed under the agreement will be Baymix Grobig BS. Source: Brakke Consulting

A breakthrough product by Neogen, the NeoSEEK Pathogen Detection system offers next day DNA diagnosis of a number of strains of E-coli in any food sample type. Detection is swift, definitive and allows for much faster treatment.

Identifying by DNA poses many advantages to vets. Rapid diagnosis benefits everyone so long as accuracy if maintained. Click here for the full release from News-Medical.